Regulus Therapeutics Inc. (NASDAQ: RGLS) announced that Kleanthis G. Xanthopoulos, Ph.D. has resigned as President and Chief Executive Officer and ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE